Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery

M. Carrier, P. Ménasché, J. H. Levy, M. F. Newman, K. M. Taylor, A. Haverich, J. C. Chen, S. K. Shernan, F. Van De Werf, M. Van Der Laan, T. G. Todaro, P. X. Adams, E. D. Verrier

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Fingerprint

Dive into the research topics of 'Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery'. Together they form a unique fingerprint.

Medicine and Dentistry